OMBIQUE

EUIPO EUIPO 2014 Trademark registered

The displayed mark can be extended.
Click here, to extend trademark protection for a further 10 years.

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark OMBIQUE was filed as Word mark on 03/24/2014 at the European Union Intellectual Property Office.
It was registered as a trademark on 10/22/2014. The current status of the mark is "Trademark registered".

Extend brand

Trademark Details Last update: February 9, 2024

Trademark form Word mark
File reference 012721957
Application date March 24, 2014
Publication date July 15, 2014
Entry date October 22, 2014
Expiration date March 24, 2024

Trademark owner

Lilly Corporate Center
46285 Indianapolis,
US

Trademark representatives

Widenmayerstr. 10 80538 München DE

goods and services

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and diagnosis of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia and dermatological diseases and disorders; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and diagnosis of diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders and pain; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and diagnosis of pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders and urological disorders; antidepressants; Diagnostic agents, preparations and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases; pharmaceutical preparations

Trademark history

Date Document number Area Entry
August 27, 2023 Extension, Notification of expiry of trade mark
April 5, 2019 Change Representative, Published
December 20, 2018 Change Representative, Published

ID: 11012721957